Literature DB >> 28496776

AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

Nasir Shariff1, Abdul Aleem2, Mukesh Singh3, Yuan Z Li4, Stacey J Smith4.   

Abstract

Atrial fibrillation (AF) and venous thromboembolism (VTE) are the two most common medical conditions managed with anti-coagulation therapy. Not all the patients with decreased mobility or AF have a similar risk for thromboembolism. The risk factors for venous thromboembolism and thromboembolism associated with AF are described in various studies. Considering that the two conditions have similar pathophysiologic basis of clot formation, one could imply that the risk factors for the occurrence of thrombosis could be similar. The present review focuses on the similarities and differences in the clinical risk factors of VTE and AF related thromboembolism. We will also be discussing the role of CHADS2-VASc scoring system in the risk assessment of VTE.

Entities:  

Year:  2012        PMID： 28496776      PMCID： PMC5153216          DOI： 10.4022/jafib.649

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  98 in total

1.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

2.  Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

Authors:  Carl van Walraven; Robert G Hart; Daniel E Singer; Andreas Laupacis; Stuart Connolly; Palle Petersen; Peter J Koudstaal; Yuchiao Chang; Beppie Hellemons
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

3.  Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.

Authors:  Jonas Bjerring Olesen; Laurent Fauchier; Deirdre A Lane; Sophie Taillandier; Gregory Y H Lip
Journal:  Chest       Date:  2011-06-16       Impact factor: 9.410

4.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

Authors:  M M Samama
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

5.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

Authors:  John A Heit; W Michael O'Fallon; Tanya M Petterson; Christine M Lohse; Marc D Silverstein; David N Mohr; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-06-10

Review 6.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

7.  Deep venous thrombosis in peripheral vascular disease.

Authors:  G Libertiny; L Hands
Journal:  Br J Surg       Date:  1999-07       Impact factor: 6.939

Review 8.  Venous thromboembolism: disease burden, outcomes and risk factors.

Authors:  J A Heit
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

9.  Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging.

Authors:  J Kelly; A Rudd; R R Lewis; C Coshall; A Moody; B J Hunt
Journal:  Stroke       Date:  2004-08-19       Impact factor: 7.914

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  6 in total

1.  Identifying mutation-driven changes in gene functionality that lead to venous thromboembolism.

Authors:  Yanran Wang; Yana Bromberg
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.878

2.  Does gender bias affect outcomes in mitral valve surgery for degenerative mitral regurgitation?

Authors:  Viswajit Kandula; Olga N Kislitsina; Vera H Rigolin; James D Thomas; S Chris Malaisrie; Adin-Cristian Andrei; Ashvita Ramesh; Jane Kruse; James L Cox; Patrick M McCarthy
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-18

Review 3.  Perioperative management of anticoagulant therapy.

Authors:  Johanna Wagner; Johan F Lock; Carolin Kastner; Ingo Klein; Katica Krajinovic; Stefan Löb; Christoph-Thomas Germer; Armin Wiegering
Journal:  Innov Surg Sci       Date:  2019-07-18

4.  Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality.

Authors:  Roubi Kilo; Silvy Laporte; Rama Arab; Sabine Mainbourg; Steeve Provencher; Guillaume Grenet; Laurent Bertoletti; Laurent Villeneuve; Michel Cucherat; Jean-Christophe Lega
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

5.  A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke.

Authors:  Oluyemisi Amoda; Elmarie A; Ese Uwagbale
Journal:  Cureus       Date:  2021-06-25

6.  Variability of the Left Atrial Appendage in Human Hearts.

Authors:  Rafał Kamiński; Adam Kosiński; Mariola Brala; Grzegorz Piwko; Ewa Lewicka; Alicja Dąbrowska-Kugacka; Grzegorz Raczak; Dariusz Kozłowski; Marek Grzybiak
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.